Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41571-023-00788-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004-2023).
Front Pharmacol
November 2024
Department of Endocrinology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
Background: This study analyzed the FDA's Adverse Event Reporting System (FAERS) data to investigate the correlation between oral bisphosphonates (BPs) and oesophageal adverse events (AEs).
Methods: We systematically extracted data on adverse reactions to oral alendronate, risedronate, and ibandronate from the FAERS database, covering the period from the 2004 Q1 to the 2023 Q4. The role_code of AEs mainly includes primary suspect (PS), secondary suspect (SS), concomitant (C), and interaction (I).
Reevaluating ADHD and its First-Line Treatment: Insights from DSM-5-TR and Modern Approaches.
Clin Neuropsychiatry
October 2024
Ariel University, University of Cambridge.
Is Attention Deficit Hyperactivity Disorder (ADHD) a "brain disorder"? Should it be managed regularly with stimulant drugs? This article critically examines the evolving biomedical discourse surrounding these questions through a close inspection of the latest edition of the influential psychiatric manual - the DSM-5-TR - as well as additional authoritative sources (e.g., previous DSM editions, consensus statements, FDA communications).
View Article and Find Full Text PDFThe Science of Biosimilars-Updating Interchangeability.
JAMA
October 2024
Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, US Food and Drug Administration, Silver Spring, Maryland.
The FDA's latest draft guidance on accelerated approvals - one step forward, two steps back?
Nat Rev Clin Oncol
September 2023
Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.